Latest Interviews
“Si las próximas elecciones no afectan negativamente la inversión minera, veremos una ola de proyectos que llevan años en pausa, lo que aumentará la demanda de EIAs, líneas base y otros estudios clave.”
62295
“We see the Au-Pb-Zn Nazas property becoming the nucleus of a new company, a spin-out from Southern Silver with clear dividend and warrant benefits.”
62273
"Small molecule drugs dominate pharmaceutical development, holding almost 60% of the market in 2024, and FDA approvals for small molecules are expected to stay strong."
62271
"We balance the need for speed in drug development with strict regulatory requirements by focusing on robust data, sound justifications and a well-structured technical package."
62269
"There is an urgent need to explore deeper and utilize advanced technology to efficiently discover and develop additional gas reserves."
62267
"Along with our extensive gold reserves, we have the necessary capital to execute our growth strategy and a strong track record of building mining companies, having previously founded Endeavour Mining and Leagold."